Protalix Biotherapeutics Inc (NYSE MKT LLC:PLX)

1.86
Delayed Data
As of 2:27pm ET
 -0.10 / -5.10%
Today’s Change
1.53
Today|||52-Week Range
3.65
+1.09%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-36.5M-11.6M-27.8M-29.9M
 
 
 
 
 
Depreciation3.6M3.7M3.5M3.1M
 
 
 
 
 
Total Other Cash Flow1.4M7.8M4.1M3.2M
 
 
 
 
 
Funds From Operations-31.5M-106.0K-20.2M-23.6M
 
 
 
 
 
Funds From/For Other Operating Expenses-7.9M-741.0K10.5M5.7M
 
 
 
 
 
Net Cash Flow - Operating Activities-23.6M635.0K-30.7M-29.3M
 
 
 
 
 
 
InvestingCapital Expenditures-5.7M-2.1M-1.9M-785.0K
 
 
 
 
 
Fixed Asset Disposal2.0K0.000.0011.0K
 
 
 
Other Investing - Uses-165.0K-218.0K-212.0K-227.0K
 
 
 
 
 
Net Cash Flow Investing-5.9M-2.3M-2.1M-1.0M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.0066.8M0.00
 
 
Long Term Debt Reduction0.000.00--0.00--
Net Proceeds Stock Sale20.9M26.6M112.0K46.0K
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing20.9M26.6M66.9M46.0K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-388.0K127.0K226.0K-1.4M
 
 
 
 
 
 
Net Change In Cash-8.5M24.9M34.1M-30.2M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account